NASDAQ
E-therapeutics Plc (ETXPF) has a fcf yield of -21.84% as of Monday, August 3, 2026. This represents a 155.70% decrease compared to its 12-month average of -8.54%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.